Skip to main content
IC

Carly Kenselaar

Stock Analyst at Citigroup

(3.08)
# 985
Out of 4,831 analysts
6
Total ratings
80%
Success rate
68.32%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology

Stocks Rated by Carly Kenselaar

Travere Therapeutics
Feb 24, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $20.94
Upside: +67.14%
Krystal Biotech
Oct 12, 2023
Initiates: Buy
Price Target: $160
Current: $134.53
Upside: +18.93%